------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    G.D. Searle & Co. said the Food and Drug Administration approved the sale of Kerlone, a hypertension drug developed by a
    joint venture between Searle and a French concern.

Treebanked sentence:
--------------------
    G.D. Searle & Co. said 0 the Food and Drug Administration approved the sale of Kerlone , a hypertension drug developed *
    by a joint venture between Searle and a French concern .

Tree:
-----
    (TOP (S (NP-SBJ (NNP G.D.)
                    (NNP Searle)
                    (CC &)
                    (NNP Co.))
            (VP (VBD said)
                (SBAR (-NONE- 0)
                      (S (NP-SBJ (DT the)
                                 (NML (NNP Food)
                                      (CC and)
                                      (NNP Drug))
                                 (NNP Administration))
                         (VP (VBD approved)
                             (NP (NP (DT the)
                                     (NN sale))
                                 (PP (IN of)
                                     (NP (NP (NNP Kerlone))
                                         (, ,)
                                         (NP (NP (DT a)
                                                 (NN hypertension)
                                                 (NN drug))
                                             (VP (VBN developed)
                                                 (NP (-NONE- *))
                                                 (PP (IN by)
                                                     (NP-LGS (NP (DT a)
                                                                 (JJ joint)
                                                                 (NN venture))
                                                             (PP (IN between)
                                                                 (NP (NP (NNP Searle))
                                                                     (CC and)
                                                                     (NP (DT a)
                                                                         (JJ French)
                                                                         (NN concern)))))))))))))))
            (. .)))

Leaves:
-------
    0   G.D.
           name:  ORG                0-3    G.D. Searle & Co.
    1   Searle
    2   &
    3   Co.
    4   said
           prop:  say.01
            v          * -> 4:0,  said
            ARG0       * -> 0:1,  G.D. Searle & Co.
            ARG1       * -> 5:1,  0 the Food and Drug Administration approved the sale of Kerlone , a hypertension drug
                                  developed * by a joint venture between Searle and a French concern
    5   0
    6   the
           name:  ORG                6-10   the Food and Drug Administration
    7   Food
    8   and
    9   Drug
    10  Administration
    11  approved
           prop:  approve.01
            v          * -> 11:0, approved
            ARG0       * -> 6:1,  the Food and Drug Administration
            ARG1       * -> 12:2, the sale of Kerlone , a hypertension drug developed * by a joint venture between
                                  Searle and a French concern
    12  the
    13  sale
    14  of
    15  Kerlone
    16  ,
    17  a
    18  hypertension
    19  drug
    20  developed
           prop:  develop.02
            v          * -> 20:0, developed
            ARG1       * -> 21:0, *
            ARG0       * -> 22:1, by a joint venture between Searle and a French concern
            LINK-PCR   * -> 17:1, a hypertension drug
                       * -> 21:0, *
    21  *
    22  by
    23  a
    24  joint
    25  venture
    26  between
    27  Searle
           name:  ORG                27-27  Searle
    28  and
    29  a
    30  French
           name:  NORP               30-30  French
    31  concern
    32  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    Searle, a unit of Monsanto Co., said the `` beta-blocker '' high-blood-pressure drug Kerlone is the first product to
    reach the market through Lorex Pharmaceuticals, the U.S. company jointly owned by Searle and Synthelabo, a French
    pharmaceutical concern owned by France's L'Oreal S.A.

Treebanked sentence:
--------------------
    Searle , a unit of Monsanto Co. , said 0 the `` beta - blocker '' high - blood - pressure drug Kerlone is the first
    product 0 *T*-1 to reach the market through Lorex Pharmaceuticals , the U.S. company jointly owned * by Searle and
    Synthelabo , a French pharmaceutical concern owned * by France 's L'Oreal S.A .

Tree:
-----
    (TOP (S (NP-SBJ (NP (NNP Searle))
                    (, ,)
                    (NP (NP (DT a)
                            (NN unit))
                        (PP (IN of)
                            (NP (NNP Monsanto)
                                (NNP Co.))))
                    (, ,))
            (VP (VBD said)
                (SBAR (-NONE- 0)
                      (S (NP-SBJ (NP (DT the)
                                     (`` ``)
                                     (NML (NN beta)
                                          (HYPH -)
                                          (NN blocker))
                                     ('' '')
                                     (NML (JJ high)
                                          (HYPH -)
                                          (NN blood)
                                          (HYPH -)
                                          (NN pressure))
                                     (NN drug))
                                 (NP (NNP Kerlone)))
                         (VP (VBZ is)
                             (NP-PRD (NP (DT the)
                                         (JJ first)
                                         (NN product))
                                     (SBAR (WHNP-1 (-NONE- 0))
                                           (S (NP-SBJ (-NONE- *T*-1))
                                              (VP (TO to)
                                                  (VP (VB reach)
                                                      (NP (DT the)
                                                          (NN market))
                                                      (PP (IN through)
                                                          (NP (NP (NNP Lorex)
                                                                  (NNP Pharmaceuticals))
                                                              (, ,)
                                                              (NP (NP (DT the)
                                                                      (NNP U.S.)
                                                                      (NN company))
                                                                  (VP (ADVP (RB jointly))
                                                                      (VBN owned)
                                                                      (NP (-NONE- *))
                                                                      (PP (IN by)
                                                                          (NP-LGS (NP (NNP Searle))
                                                                                  (CC and)
                                                                                  (NP (NP (NNP Synthelabo))
                                                                                      (, ,)
                                                                                      (NP (NP (DT a)
                                                                                              (JJ French)
                                                                                              (JJ pharmaceutical)
                                                                                              (NN concern))
                                                                                          (VP (VBN owned)
                                                                                              (NP (-NONE- *))
                                                                                              (PP (IN by)
                                                                                                  (NP-LGS (NP (NNP France)
                                                                                                              (POS 's))
                                                                                                          (NNP L'Oreal)
                                                                                                          (NNP
    S.A)))))))))))))))))))))
            (. .)))

Leaves:
-------
    0   Searle
           name:  ORG                0-0    Searle
    1   ,
    2   a
    3   unit
    4   of
    5   Monsanto
           name:  ORG                5-6    Monsanto Co.
    6   Co.
    7   ,
    8   said
           prop:  say.01
            v          * -> 8:0,  said
            ARG0       * -> 0:2,  Searle , a unit of Monsanto Co. ,
            ARG1       * -> 9:1,  0 the `` beta - blocker '' high - blood - pressure drug Kerlone is the first product 0
                                  *T*-1 to reach the market through Lorex Pharmaceuticals , the U.S. company jointly
                                  owned * by Searle and Synthelabo , a French pharmaceutical concern owned * by France
                                  's L'Oreal S.A
    9   0
    10  the
    11  ``
    12  beta
    13  -
    14  blocker
    15  ''
    16  high
    17  -
    18  blood
    19  -
    20  pressure
    21  drug
    22  Kerlone
    23  is
           prop:  be.01
            v          * -> 23:0, is
            ARG1       * -> 10:2, the `` beta - blocker '' high - blood - pressure drug Kerlone
            ARG2       * -> 24:2, the first product 0 *T*-1 to reach the market through Lorex Pharmaceuticals , the U.S.
                                  company jointly owned * by Searle and Synthelabo , a French pharmaceutical concern
                                  owned * by France 's L'Oreal S.A
    24  the
    25  first
    26  product
    27  0
    28  *T*-1
    29  to
    30  reach
           prop:  reach.01
            v          * -> 30:0, reach
            ARG0       * -> 28:0, *T*-1 -> 27:0, 0
            ARG1       * -> 31:1, the market
            ARGM-MNR   * -> 33:1, through Lorex Pharmaceuticals , the U.S. company jointly owned * by Searle and
                                  Synthelabo , a French pharmaceutical concern owned * by France 's L'Oreal S.A
            LINK-SLC   * -> 24:1, the first product
                       * -> 28:0, *T*-1 -> 27:0, 0
    31  the
    32  market
    33  through
    34  Lorex
           name:  ORG                34-35  Lorex Pharmaceuticals
    35  Pharmaceuticals
    36  ,
    37  the
    38  U.S.
           name:  GPE                38-38  U.S.
    39  company
    40  jointly
    41  owned
           prop:  own.01
            v          * -> 41:0, owned
            ARG1       * -> 42:0, *
            ARGM-MNR   * -> 40:1, jointly
            ARG0       * -> 43:1, by Searle and Synthelabo , a French pharmaceutical concern owned * by France 's
                                  L'Oreal S.A
            LINK-PCR   * -> 37:1, the U.S. company
                       * -> 42:0, *
    42  *
    43  by
    44  Searle
           name:  ORG                44-44  Searle
    45  and
    46  Synthelabo
           name:  ORG                46-46  Synthelabo
    47  ,
    48  a
    49  French
           name:  NORP               49-49  French
    50  pharmaceutical
    51  concern
    52  owned
           prop:  own.01
            v          * -> 52:0, owned
            ARG1       * -> 53:0, *
            ARG0       * -> 54:1, by France 's L'Oreal S.A
            LINK-PCR   * -> 48:1, a French pharmaceutical concern
                       * -> 53:0, *
    53  *
    54  by
    55  France
           name:  GPE                55-55  France
    56  's
    57  L'Oreal
        !  name:  ORG                57-58  L'Oreal S.A
    58  S.A
    59  .

